Published in Genes Immun on September 01, 1999
Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol (2005) 1.30
Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis. Cell Mol Life Sci (2008) 1.00
Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda. J Acquir Immune Defic Syndr (2009) 0.90
CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women. BMC Cancer (2010) 0.87
Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents. PLoS One (2010) 0.83
Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes. Virology (2009) 0.83
Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters. PLoS One (2014) 0.75
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med (1999) 16.35
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med (1991) 4.60
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci U S A (1986) 3.76
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61
Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. Nature (1990) 3.54
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Detection and treatment of hypertension at the work site. N Engl J Med (1975) 3.43
Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med (1995) 3.26
Couple communication, sexual coercion and HIV risk reduction in Kigali, Rwanda. AIDS (1995) 2.97
Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature (1987) 2.82
Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics (1999) 2.69
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65
Sexual practices of HIV discordant and concordant couples in Rwanda: effects of a testing and counselling programme for men. Int J STD AIDS (2001) 2.46
Anxiety and sleep after fosazepam. Br J Clin Pharmacol (1976) 2.42
An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol (1992) 2.41
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Arch Intern Med (1988) 2.30
Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol (1987) 2.29
Clinical comparison of a new automated infrared blood culture system with the BACTEC 460 system. J Clin Microbiol (1986) 2.28
Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods. J Infect Dis (2000) 2.25
Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses (2001) 2.23
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet (1993) 2.18
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1988) 2.18
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J Clin Microbiol (1998) 2.09
Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet Immunol Immunopathol (1989) 2.09
Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med (1992) 2.03
Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.99
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep (1998) 1.98
HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. AIDS (1999) 1.96
Massive Hematemesis : Analysis of 300 consecutive cases. Ann Surg (1949) 1.92
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Prediction of mortality by exercise echocardiography: a strategy for combination with the duke treadmill score. Circulation (2001) 1.92
Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J Biol Chem (2000) 1.91
Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med (1986) 1.89
Human immunodeficiency virus transmission among heterosexual couples in Central Africa. AIDS (1988) 1.87
Mechanisms of GDF-5 action during skeletal development. Development (1999) 1.83
Occurrence, predictors, and consequences of adult asthma in NHANESI and follow-up survey. Am Rev Respir Dis (1989) 1.83
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83
Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med (1999) 1.82
Helmets, injuries and cultural definitions: motorcycle injury in urban Indonesia. Accid Anal Prev (1996) 1.82
Characteristics of motor unit discharge in subjects with hemiparesis. Muscle Nerve (1995) 1.82
Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg (1992) 1.81
Smoking cessation in women concerned about weight. Am J Public Health (1992) 1.79
Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology (1997) 1.79
Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum (1978) 1.75
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med (1985) 1.71
Rapid voluntary testing and counseling for HIV. Acceptability and feasibility in Zambian antenatal care clinics. Ann N Y Acad Sci (2000) 1.69
Transhepatic PermCath for hemodialysis. Am J Kidney Dis (1994) 1.68
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68
Aqueous quaternary ammonium antiseptics and disinfectants. Use and misuse. JAMA (1976) 1.67
Sensitizing students to functional limitations in the elderly: an aging simulation. Fam Med (1998) 1.66
Signs and symptoms of "asymptomatic" HIV-1 infection in homosexual men. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1993) 1.66
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
Infections complicating low-risk cesarean sections in community hospitals: efficacy of antimicrobial prophylaxis. Am J Obstet Gynecol (1990) 1.63
HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses (1999) 1.61
The social impact of HIV infection on women in Kigali, Rwanda: a prospective study. Soc Sci Med (1994) 1.61
Racial and ethnic differences in human immunodeficiency virus type 1 (HIV-1) seroprevalence among homosexual and bisexual men. The Multicenter AIDS Cohort Study. Am J Epidemiol (1993) 1.61
The psychosocial impact of cancer on older versus younger patients and their families. Cancer (1994) 1.61
Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis (1999) 1.60
The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum (1996) 1.60
Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab (1999) 1.60
Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc (1985) 1.59
A distinct African lentivirus from Sykes' monkeys. J Virol (1993) 1.58
The Practical Approach to Lung Health in South Africa (PALSA) intervention: respiratory guideline implementation for nurse trainers. Int Nurs Rev (2006) 1.58
Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med (1993) 1.58
The major neutral proteinase of Entamoeba histolytica. J Exp Med (1986) 1.56
Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J Biol Chem (1986) 1.55
Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group. N Engl J Med (1990) 1.55
Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: evidence of contact transmission. Am J Trop Med Hyg (1986) 1.55
Public Health Service study on Reye's syndrome and medications. Report of the pilot phase. N Engl J Med (1985) 1.54
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
Genome amplification and gene expression in the ciliate macronucleus. Biochem Genet (1972) 1.53
Public Health Service study of Reye's syndrome and medications. Report of the main study. JAMA (1987) 1.47
Verapamil: a new antimanic drug with potential interactions with lithium. J Clin Psychiatry (1987) 1.47